Gene Editing Therapy Halves Cholesterol Levels in Early Trials
TL;DR Summary
A small clinical trial using CRISPR gene editing successfully reduced LDL cholesterol and triglycerides by 50% in participants, indicating potential for gene therapy to treat heart disease, with ongoing safety monitoring and plans for larger studies.
- A Gene Editing Therapy Cut Cholesterol Levels by Half WIRED
- Scientists have edited a gene that may reduce high cholesterol permanently CNN
- CRISPR gene-editing works to reduce high cholesterol in a new study NPR
- Harmful cholesterol levels cut in half with one-time gene editing drug in early trial NBC News
- CRISPR-based treatment cuts cholesterol and triglycerides in early study statnews.com
Reading Insights
Total Reads
0
Unique Readers
18
Time Saved
4 min
vs 5 min read
Condensed
96%
808 → 36 words
Want the full story? Read the original article
Read on WIRED